Drug General Information
Drug ID
D0L1UH
Former ID
DIB008533
Drug Name
ASP-0777
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 1 [523568]
Company
Astellas Pharma Inc
Target and Pathway
Target(s) NMDA receptor Target Info Modulator [551922]
References
Ref 523568ClinicalTrials.gov (NCT01406145) A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil. U.S. National Institutes of Health.
Ref 551922US patent application no. 2011,0262,442, Compositions for treating cns disorders.